Quest Diagnostics Inc. (DGX) About to Explode

Company Profile:

Quest Diagnostics Incorporated provides diagnostic testing information services in the United States and internationally. The company offers clinical testing services, such as routine testing, gene-based and esoteric testing, anatomic pathology services, and drugs-of-abuse testing, as well as related services and insights; laboratory testing services for new drugs, vaccines, and medical devices; analytic, on-site prevention, and wellness services; and risk assessment services for the life insurance industry. It also develops, manufactures, and markets diagnostic products, including Simplexa molecular chemistries for testing infectious disease and hospital-acquired infections; HerpeSelect HSV serology; and DxSelect IFA and ELISA products for testing infectious diseases. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Madison, New Jersey.

Recent News:

Quest Diagnostics Incorporated announced that it will report second quarter 2015 results on Thursday, July 23, 2015, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.

On June 30, 2015, Quest Diagnostics and MemorialCare Health System announced they have entered into a definitive agreement for Quest to acquire MemorialCare Health System’s laboratory outreach service business.

On June 30, 2015, HealthTap and Quest Diagnostics announced a collaboration that will enable doctors to order diagnostic testing services for patients through HealthTap’s comprehensive virtual care platform.

 

Fundamental Analysis:

Ninestocks analyzes several different financial aspects: Growth, Profitability, solvency and efficiency.

Growth – Measures the growth of both the company’s income statement and cash flow.

@@@@@

Profitability – Measures the historical price movement of the stock.

@@@@@

Solvency – Measures the solvency of the company based on several ratios.

@@@@@

Efficiency – Measures the strength and historic growth of a company’s return on invested capital.

@@@@@

Conclusion:

DGX’s strengths can be seen in its better profitability and strong Solvency. Technical indicators signal the bullish signs, as there is a bullish cross in MACD and Stochastic Oscillator. RSI is increasing to 46.20. The current P/E ratio indicates it is undervalued compared to the average P/E ratio of the industry and the sector. We rate Quest Diagnostics Inc. (DGX) a BUY.


Posted

in

by

Tags:

Comments

Leave a Reply